Tata Nifty MidSmall Healthcare Index Fund Regular Growth

+

Index Funds
Index Funds
Rating N.A.
Plan

11.89 +0.07 (0.60%) NAV as on 17 Apr, 2025

5D
1M
6M
1Y
5Y
MAX

Key Metrics

AUM (in Cr)133.47
CAGR 0.00%
Exit Load0.25%
Expense ratio1.10%
CategoryIndex Funds
Min Investment5000
Min SIP500
Launch Date2024-04-26

Asset Allocation

Holdings As On - 21 April 2025

Holdings

Sectors

Name
Value (Cr)
Holding %

Lupin
11.89
8.90%

Fortis Healthcare
8.83
6.62%

Aurobindo Pharma
7.88
5.90%

Mankind Pharma
6.64
4.97%

Alkem Laboratories
6.30
4.72%

Laurus Labs
5.83
4.36%

Ipca Laboratories
5.07
3.79%

Abbott India
3.89
2.91%

Peer Comparison

Risk & Volitility

Alpha 0.00%
Beta 0.00
Sharpe Ratio0.00
Std Deviation 0.00%
Tracking Error 0.00%

About Fund

The investment objective of the scheme is to provide returns, before expenses, that are in line with the performance of Nifty MidSmall Healthcare Index (TRI), subject to tracking error.

The Tata Nifty MidSmall Healthcare Index Fund Regular Growth has an AUM of 133.47 crores & has delivered CAGR of 0.00% in the last 5 years. The fund has an exit load of 0.25% and an expense ratio of 1.10%. The minimum investment in Tata Nifty MidSmall Healthcare Index Fund Regular Growth is Rs 5000 and the minimum SIP is Rs 500.

As per morningstar the risk & return rating of the fund are - & - respectively.

The top holdings of the fund include Max Healthcare Institute, Lupin, Fortis Healthcare & Aurobindo Pharma.

The major sectors where the fund is invested are Biotechnology & Drugs, Healthcare Facilities, Major Drugs & Medical Equipment & Supplies.

Some of the similar funds are Edelweiss Nifty 100 Quality 30 Index Fund Regular Growth, Nippon India Nifty Bank Index Fund Regular Growth, Tata Nifty MidSmall Healthcare Index Fund Regular Growth, Nippon India Nifty IT Index Fund Regular Growth, Axis Nifty Bank Index Fund Regular Growth. Tata Nifty MidSmall Healthcare Index Fund Regular Growth has a sharpe ratio of 0.00 & a standard deviation of 0.00%.